glp 1 cause dizziness Understanding Vertigo as a Rare GLP-1 Complication If you keep getting dizzy

AA: Data curation, Writing original draft

With Semaglutide's patent set to expire in January 2026, Indian pharma companies are preparing to introduce affordable alternatives that could dramatically lower treatment costs

Oral GLP-1 agents have been widely anticipated to expand eligible patient populations and drive further utilization among plan sponsors

For 2,567 semaglutide users who stopped treatment, 33% regained weight, 32% maintained weight loss, and 35% continued losing weight

That includes proactive management of side effects, candid conversations about the long-term nature of treatment, infrastructure to identify and support patients at risk of stopping and addressing the cost barriers that make GLP-1 therapy unsustainable for many.

Studies that examine prolonged calorie restriction report that participants show markedly less caloric expenditure from physical activity than their usual levels when in an energy deficit